Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Go back to Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron| Pfizer Inc. (NYSE: PFE) | Delayed: 27.83 -0.19 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.02 | 52 Week High | $37.39 | |||
| Open | $28.00 | 52 Week Low | $28.25 | |||
| Day High | $28.02 | P/E | 16.87 | |||
| Day Low | $27.77 | EPS | $1.65 | |||
| Volume | 12,992,035 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.83 -0.19 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.02 | 52 Week High | $37.39 | |||
| Open | $28.00 | 52 Week Low | $28.25 | |||
| Day High | $28.02 | P/E | 16.87 | |||
| Day Low | $27.77 | EPS | $1.65 | |||
| Volume | 12,992,035 | |||||

